These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 16807364)

  • 1. Inhibition of the enzymatic activity of heme oxygenases by azole-based antifungal drugs.
    Kinobe RT; Dercho RA; Vlahakis JZ; Brien JF; Szarek WA; Nakatsu K
    J Pharmacol Exp Ther; 2006 Oct; 319(1):277-84. PubMed ID: 16807364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of azole-based heme oxygenase inhibitors on rat cytochromes P450 2E1 and 3A1/2 and human cytochromes P450 3A4 and 2D6.
    Hum M; McLaughlin BE; Roman G; Vlahakis JZ; Szarek WA; Nakatsu K
    J Pharmacol Exp Ther; 2010 Sep; 334(3):981-7. PubMed ID: 20501634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxynitrite-mediated inactivation of heme oxygenases.
    Kinobe R; Ji Y; Nakatsu K
    BMC Pharmacol; 2004 Oct; 4():26. PubMed ID: 15498099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant truncated and microsomal heme oxygenase-1 and -2: differential sensitivity to inhibitors.
    Vukomanovic D; McLaughlin B; Rahman MN; Vlahakis JZ; Roman G; Dercho RA; Kinobe RT; Hum M; Brien JF; Jia Z; Szarek WA; Nakatsu K
    Can J Physiol Pharmacol; 2010 Apr; 88(4):480-6. PubMed ID: 20555417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selectivity of imidazole-dioxolane compounds for in vitro inhibition of microsomal haem oxygenase isoforms.
    Kinobe RT; Vlahakis JZ; Vreman HJ; Stevenson DK; Brien JF; Szarek WA; Nakatsu K
    Br J Pharmacol; 2006 Feb; 147(3):307-15. PubMed ID: 16331285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative prediction of metabolic inhibition of midazolam by itraconazole and ketoconazole in rats: implication of concentrative uptake of inhibitors into liver.
    Yamano K; Yamamoto K; Kotaki H; Sawada Y; Iga T
    Drug Metab Dispos; 1999 Mar; 27(3):395-402. PubMed ID: 10064572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of two azole antifungal drugs, ketoconazole, and fluconazole, as modifiers of rat hepatic monooxygenase activity.
    Houston JB; Humphrey MJ; Matthew DE; Tarbit MH
    Biochem Pharmacol; 1988 Feb; 37(3):401-8. PubMed ID: 2827686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cytochrome p450 inhibitor ketoconazole potentiates 5-hydroxytryptamine-induced contraction in rat aorta.
    Ogden KK; Falck JR; Watts SW
    J Pharmacol Exp Ther; 2007 Nov; 323(2):606-13. PubMed ID: 17687070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An inhibition study of beauvericin on human and rat cytochrome P450 enzymes and its pharmacokinetics in rats.
    Mei L; Zhang L; Dai R
    J Enzyme Inhib Med Chem; 2009 Jun; 24(3):753-62. PubMed ID: 18956271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective inhibition of heme oxygenase, without inhibition of nitric oxide synthase or soluble guanylyl cyclase, by metalloporphyrins at low concentrations.
    Appleton SD; Chretien ML; McLaughlin BE; Vreman HJ; Stevenson DK; Brien JF; Nakatsu K; Maurice DH; Marks GS
    Drug Metab Dispos; 1999 Oct; 27(10):1214-9. PubMed ID: 10497150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histopathological and immunohistochemical alterations in rat heart after thyroidectomy and the role of hemin and ketoconazole in treatment.
    Tousson E; Ali EM; Ibrahim W; Ashraf RM
    Biomed Pharmacother; 2012 Dec; 66(8):627-32. PubMed ID: 23089472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential inhibition of rat and mouse microsome heme oxygenase by derivatives of imidazole and benzimidazole.
    Hum M; McLaughlin BE; Kong X; Vlahakis JZ; Vukomanovic D; Szarek WA; Nakatsu K
    Can J Physiol Pharmacol; 2017 Dec; 95(12):1454-1461. PubMed ID: 28793202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effects of ketoconazole, cimetidine and erythromycin on hepatic CYP3A activities in cats.
    Shah SS; Sasaki K; Hayashi Y; Motoyama S; Helmi AR; Khalil WF; Shimoda M
    J Vet Med Sci; 2009 Sep; 71(9):1151-9. PubMed ID: 19801894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enantioselectivity of inhibition of cytochrome P450 3A4 (CYP3A4) by ketoconazole: Testosterone and methadone as substrates.
    Dilmaghanian S; Gerber JG; Filler SG; Sanchez A; Gal J
    Chirality; 2004 Feb; 16(2):79-85. PubMed ID: 14712470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of ketoconazole and fluconazole as cytochrome P450 inhibitors. Use of steady-state infusion approach to achieve plasma concentration-response relationships.
    Ervine CM; Matthew DE; Brennan B; Houston JB
    Drug Metab Dispos; 1996 Feb; 24(2):211-5. PubMed ID: 8742233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-drug interactions between ketoconazole and berberine in rats: pharmacokinetic effects benefit pharmacodynamic synergism.
    Zhou Y; He P; Liu A; Zhang L; Liu Y; Dai R
    Phytother Res; 2012 May; 26(5):772-7. PubMed ID: 22114028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric oxide metabolism in mammalian cells: substrate and inhibitor profiles of a NADPH-cytochrome P450 oxidoreductase-coupled microsomal nitric oxide dioxygenase.
    Hallstrom CK; Gardner AM; Gardner PR
    Free Radic Biol Med; 2004 Jul; 37(2):216-28. PubMed ID: 15203193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of oral ketoconazole on oral and intravenous pharmacokinetics of simvastatin and its acid in cynomolgus monkeys.
    Ogasawara A; Utoh M; Nii K; Ueda A; Yoshikawa T; Kume T; Fukuzaki K
    Drug Metab Dispos; 2009 Jan; 37(1):122-8. PubMed ID: 18854378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple oral dosing of ketoconazole influences pharmacokinetics of quinidine after intravenous and oral administration in beagle dogs.
    Kuroha M; Shirai Y; Shimoda M
    J Vet Pharmacol Ther; 2004 Oct; 27(5):355-9. PubMed ID: 15500574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Piperazine-Modified Ketoconazole Derivatives Show Increased Activity against Fungal and Trypanosomatid Pathogens.
    Štěpánek O; Čmoková A; Procházková E; Grobárová V; Černý J; Slapničková M; Zíková A; Kolařík M; Baszczyňski O
    ChemMedChem; 2022 Nov; 17(21):e202200385. PubMed ID: 36115047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.